Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103(+) dendritic cells in late-stage ovarian cancer.

Flies, Dallas B; Higuchi, Tomoe; Harris, Jaryse C; Jha, Vibha; Gimotty, Phyllis A; Adams, Sarah F

Flies, Dallas B; Higuchi, Tomoe; Harris, Jaryse C; Jha, Vibha; Gimotty, Phyllis A; Adams, Sarah F.

Afiliação

Flies DB; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center , Albuquerque, NM, USA.
Higuchi T; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center , Albuquerque, NM, USA.
Harris JC; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center , Albuquerque, NM, USA.
Jha V; Ovarian Cancer Research Center, The University of Pennsylvania , Philadelphia, PA, USA.
Gimotty PA; Department of Biostatistics, The University of Pennsylvania , Philadelphia, PA, USA.
Adams SF; Division of Gynecologic Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA; Ovarian Cancer Research Center, The University of Pennsylvania, Philadelphia, PA, USA.

Oncoimmunology ; 5(8): e1185583, 2016 Aug.

Article em En | MEDLINE | ID: mdl-27622059

Palavras-chave

CD103+; Lair-1; PD-1; T cell exhaustion; dendritic cells; ovarian cancer; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article